Identification Of Osimertinib Resistance Mechanisms In Chinese Nsclc Patients: Analysis From Aura17 Trial.Min Hu,Yi-Long Wu,Xuehua Zhu,Yun Sun,Xuesong Lu, Jia Wang,Mengzhao Wang,Ying Cheng,Yuan Chen,Yanqiu Zhao,Yuankai Shi,You Lu,Meiqi Shi,Helong Zhang,Xiangning Huang, Zhijie Ding, George Zhijian Chen,Caicun ZhouJOURNAL OF CLINICAL ONCOLOGY(2018)引用 2|浏览24暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要